MH
Mark Hopman sold $12K of BBNX stock
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (BBNX), sold 775 shares of BBNX stock worth $12K, per an SEC Form 4 filed Sep 15, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 14, 2026, 1 day before it was made public.
BBNX has moved -20.4% since the trade date, from $16.73 to $13.32 (Nov 19, 2026 close).
- Traded
- Sep 14, 2026
- Disclosed
- Sep 15, 2026
- Filing delay
- 1 day
- Price since
- -20.4%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4